American Century Companies’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,773
| Closed | -$1.42M | – | 2988 |
|
|
2025
Q1 | $1.42M | Sell |
10,773
-303,589
| -97% | -$40M | ﹤0.01% | 2114 |
|
|
2024
Q4 | $26.3M | Buy |
314,362
+63,423
| +25% | +$5.3M | 0.02% | 922 |
|
|
2024
Q3 | $18.4M | Sell |
250,939
-18,044
| -7% | -$1.32M | 0.01% | 1059 |
|
|
2024
Q2 | $18.4M | Sell |
268,983
-273,930
| -50% | -$18.8M | 0.01% | 990 |
|
|
2024
Q1 | $37.6M | Buy |
542,913
+62,663
| +13% | +$4.34M | 0.02% | 670 |
|
|
2023
Q4 | $34.4M | Buy |
480,250
+38,840
| +9% | +$2.78M | 0.02% | 652 |
|
|
2023
Q3 | $23M | Buy |
441,410
+21,604
| +5% | +$1.13M | 0.02% | 754 |
|
|
2023
Q2 | $26.6M | Buy |
419,806
+76,429
| +22% | +$4.84M | 0.02% | 661 |
|
|
2023
Q1 | $18.6M | Buy |
343,377
+3,715
| +1% | +$201K | 0.01% | 784 |
|
|
2022
Q4 | $18M | Buy |
339,662
+21,867
| +7% | +$1.16M | 0.01% | 764 |
|
|
2022
Q3 | $14.8M | Sell |
317,795
-1,504
| -0.5% | -$70K | 0.01% | 753 |
|
|
2022
Q2 | $18.2M | Buy |
319,299
+128,636
| +67% | +$7.34M | 0.01% | 705 |
|
|
2022
Q1 | $11.7M | Buy |
190,663
+181,156
| +1,906% | +$11.1M | 0.01% | 858 |
|
|
2021
Q4 | $498K | Buy |
9,507
+886
| +10% | +$46.4K | ﹤0.01% | 1931 |
|
|
2021
Q3 | $321K | Buy |
8,621
+703
| +9% | +$26.2K | ﹤0.01% | 2059 |
|
|
2021
Q2 | $323K | Buy |
+7,918
| New | +$323K | ﹤0.01% | 2032 |
|
|
2018
Q1 | – | Sell |
-65,330
| Closed | -$946K | – | 1351 |
|
|
2017
Q4 | $946K | Hold |
65,330
| – | – | ﹤0.01% | 1109 |
|
|
2017
Q3 | $1.03M | Buy |
+65,330
| New | +$1.03M | ﹤0.01% | 1139 |
|
|
2016
Q3 | – | Sell |
-48,896
| Closed | -$1.9M | – | 1424 |
|
|
2016
Q2 | $1.9M | Buy |
+48,896
| New | +$1.9M | ﹤0.01% | 1035 |
|